PVR/TIGIT and PD-L1/PD-1 expression predicts survival and enlightens combined immunotherapy in lung squamous cell carcinoma

PVR/TIGIT and PD-L1/PD-1 axes play essential roles in tumor immune evasion and could be potential targets for combined immunotherapy. We aimed to evaluate the expression status of the above-mentioned immune markers in lung squamous cell carcinoma (LUSC), and investigate their survival impact and rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhenlin, Peng, Yue, Xu, Jiachen, Chen, Ping, Zhao, Zhenshan, Cai, Qingyuan, Li, Lin, Tian, He, Bai, Guangyu, Liu, Lei, Gao, Shugeng, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352965/
https://www.ncbi.nlm.nih.gov/pubmed/35926369
http://dx.doi.org/10.1016/j.tranon.2022.101501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9352965/
https://www.ncbi.nlm.nih.gov/pubmed/35926369
http://dx.doi.org/10.1016/j.tranon.2022.101501

Ejemplares similares